Biopharma Stock Election Impact: Potential Reduced IRA Headwind but Unpredictable Challenges
In terms of industry tailwinds, Trump could lessen pressure from the Federal Trade Commission on mergers and acquisitions, ...
Viatris Inc. (NASDAQ:VTRS) Q3 2024 Earnings Call Transcript
Q3 2024 Earnings Call Transcript November 7, 2024 Operator: Good morning, everyone, and welcome to the Viatris Q3 2024 Earnings Call. All participants will be in a listen-only mode. [Operator ...
bovnews12h
Lexicon Pharmaceuticals Inc (LXRX) Stock Trading Recap
In recent trading, Lexicon Pharmaceuticals Inc (LXRX) stock price has shown some volatility, fluctuating -33.33% over the last five trades and -22.62% over the past 30 trades. This represents a ...
Business Insider16h
Strategic Positioning and Growth Potential Drive Buy Rating for Xoma
Pantginis covers the Healthcare sector, focusing on stocks such as Lexicon Pharmaceuticals, Cytokinetics, and Palatin Technologies. According to TipRanks, Pantginis has an average return of 2.2% and a ...
Ligand Pharma’s Strong Financial Performance and Strategic Growth Justifies Buy Rating
Joseph Pantginis, an analyst from H.C. Wainwright, reiterated the Buy rating on Ligand Pharma (LGND – Research Report). The associated ...